Alimera
We See More, Together™
We See More, Together™
Alimera is a global pharmaceutical company founded in 2003, with a mission to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company operates in the Biotechnology and Health Care industries, with its headquarters located in the United States. Alimera recently received a $20.00M post-IPO equity investment from Ocumension Therapeutics on 14 April 2021. Their slogan, "We See More, Together™", reflects the collaborative and patient-centered approach Alimera adopts in its pursuit of innovative solutions in the field of retinal health. For more information, please visit www.alimerasciences.com.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $20.00M | 1 | Ocumension Therapeutics | 14 Apr 2021 |
| Post-IPO Debt | $1.80M | 1 | Federal Government | 23 Apr 2020 |
| Post-IPO Equity | $26.50M | - | 17 Aug 2016 | |
| Post-IPO Equity | $50.00M | 1 | Deerfield | 28 Nov 2014 |
| Post-IPO Debt | $35.00M | 1 |
|
24 Apr 2014 |
No recent news or press coverage available for Alimera.
We care about your data, and we'd love to use cookies make your experience better.
